Key facts
- This page summarizes Kelly Gold's Form 4 filing for Camp4 Therapeutics Corp (CAMP).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2026, 16:47.
Kelly Gold - 01 Apr 2026 Form 4 Insider Report for Camp4 Therapeutics Corp (CAMP)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CAMP
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Apr 2026, 16:47:04 UTC
- Prior SEC filing
- 22 Dec 2025
- Next SEC filing
- 01 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Josh Mandel-Brehm, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kelly Gold filed Form 4 for Camp4 Therapeutics Corp (CAMP) on 03 Apr 2026.
Change
- Previous filing in this sequence was filed on 22 Dec 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002033333
Primary reporting owner
Gold Kelly
- Relationship
- Chief Financial Officer
- Address
- C/O CAMP4 THERAPEUTICS CORPORATION, ONE KENDALL SQ., BLDG 1400 WEST, 3RD FL., CAMBRIDGE
- Signature
- /s/ Josh Mandel-Brehm, as Attorney-in-Fact
- Signature date
- 03 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CAMP
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +215,000
- Change %
- Price
- $0.000000*
- Shares after
- 215,000
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 215,000
- Exercise price
- $4.46
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying the option vest in equal monthly installments over a period of four years commencing from the date of grant.